from Reuters: Health News https://ift.tt/2pN2C7L
Saturday, October 13, 2018
Saturday, October 13, 2018
MZ Digital Marketing Agency
HEALTH NEWS
No comments
Bristol-Myers Squibb Co said on Friday that its blockbuster cancer drug Opdivo failed to meet the main goal in a late-stage trial on patients with a type of lung cancer, whose condition had relapsed after chemotherapy.

from Reuters: Health News https://ift.tt/2pN2C7L
from Reuters: Health News https://ift.tt/2pN2C7L
Related Posts:
LATEST HEALTH NEWSMentioned below are few natural remedies can be an effective aid to fight the inflammatory mechanism of seasonal allergic rhinitis. from Health http://ift.tt/2FuutQn … Read More
LATEST HEALTH NEWSJOHANNESBURG (Reuters) - South African food producer Tiger Brands said on Friday it had appointed an expert team to identify the causes of a listeria outbreak that has killed 180 people in the past 14 months and which has bee… Read More
LATEST HEALTH NEWS(Reuters Health) - States with laws that make it easier for midwives to care for pregnant women and deliver babies may have better birth outcomes than states where it’s harder for midwives to provide care, a recent study sugg… Read More
LATEST HEALTH NEWSPARIS (Reuters) - Sanofi and Evotec said they had started exclusive talks over accelerating research into the treatment of infectious diseases, and added on Thursday that they would form a new open innovation platform in this… Read More
LATEST HEALTH NEWSPROVIDENCE, R.I. (Reuters) - A Rhode Island doctor was sentenced on Friday to more than four years in prison after admitting he took kickbacks from Insys Therapeutics Inc to prescribe its fentanyl-based cancer pain drug to pe… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment